景岳 3164.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 3164)
3164
景岳
20.50D
0.24%
(0.05)
3164 Value Score
3
24
15
Excellent Growth
- AI analysis rates 3164 with the highest value score of 5.
- It is mainly due to adequate operating cash flow, along with adequate saety shown in the balance sheet.
- Over the past 3 months, 3164 has maintained an average value rating of 4.3, close to the rating of 3.9 over the past 3 years, indicating stable and increasing opportunities for enterprise value growth.
- Compared to all stocks in the Biotech. & Medical sector, 3164 has a higher value rating.
3164 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/05/09 (Weekly Update)
3164 Financial Forecast
Unit : TWD
Update to 2025/5/13 (Quarterly Update)
3164 Earnings Table
No related data records
3164 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
3164 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 3164 from 2008/09 till Now
- 18.00%
- Cumulative Return
- 1.02%
- Annual Return
- 23.57%
- Volatility
- 0.04
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from September, 2008 to May, 2025. (Total Trades: 5)
| 3164 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | 60% | 46% | 53% |
| Avg Return | 3.1% | 21.1% | 45.4% |
| Avg Profit | 8.1% | 72.2% | 102.9% |
| Avg Loss | -4.5% | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | 181.2% | 322.8% | 505.8% |
Update to 2025/5/13 (Daily Update)